CM
MRNS

Caption Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Caption Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200
Closed -$234 – 1673
2024
Q2 		$234 Sell
200
-73,908
-100% -$185K ﹤0.01% 1114
2024
Q1 		$670K Buy
+74,108
New +$720K 0.01% 825
2023
Q4 		– Sell
-16,200
Closed -$121K – 1774
2023
Q3 		$130K Buy
+16,200
New +$135K ﹤0.01% 1134
2023
Q2 		– Sell
-93,778
Closed -$803K – 1477
2023
Q1 		$647K Sell
93,778
-9,244
-9% -$58K 0.01% 734
2022
Q4 		$410K Buy
+103,022
New +$506K 0.01% 963
2022
Q2 		– Sell
-15,000
Closed -$140K – 1940
2022
Q1 		$140K Buy
+15,000
New +$149K ﹤0.01% 1309
2021
Q1 		– Sell
-7,989
Closed -$98K – 1466
2020
Q4 		$98K Sell
7,989
-106,936
-93% -$1.49M ﹤0.01% 894
2020
Q3 		$1.48M Buy
114,925
+100,925
+721% +$871K 0.03% 522
2020
Q2 		$142K Hold
14,000
– – ﹤0.01% 819
2020
Q1 		$114K Hold
14,000
– – 0.01% 760
2019
Q4 		$121K Buy
14,000
+5,000
+56% +$28.1K ﹤0.01% 748
2019
Q3 		$56K Sell
9,000
-17,250
-66% -$139K ﹤0.01% 655
2019
Q2 		$436K Sell
26,250
-11,250
-30% -$195K 0.02% 499
2019
Q1 		$628K Sell
37,500
-5,000
-12% -$72K 0.03% 425
2018
Q4 		$487K Sell
42,500
-4,625
-10% -$93.6K 0.04% 342
2018
Q3 		$1.89M Buy
+47,125
New +$1.34M 0.1% 238

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Caption Management's MRNS Position: Q3 2024 in Review

Caption Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 200 shares — an estimated $234 sold.

Caption Management first reported a position in MRNS in Q3 2018 and held it in 16 quarters. The position peaked at $1.89M in Q3 2018. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

  • Caption Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 200 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $234.
  • Caption Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2018 and held it in 16 quarters.
  • Caption Management's Marinus Pharmaceuticals, Inc position peaked at $1.89M in Q3 2018.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.